세계의 류프로라이드 아세트산염 시장 : 용도별, 제품 형태별, 투여 경로별, 유통 채널별, 지역별

Global leuprolide acetate market is estimated to be valued at USD 3.82 Billion in 2024 and is expected to reach USD 5.81 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

Figure. Leuprolide Acetate Market Share (%), By Region 2024

Global leuprolide acetate market refers to the pharmaceutical market for leuprolide acetate drugs, which is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). Leuprolide acetate is used as a medication to treat prostate cancer, breast cancer, endometriosis and uterine fibroids. As an agonist of gonadotropin-releasing hormone (GnRH) receptor, leuprolide acetate works by reducing the secretion of FSH and LH from the pituitary gland which helps in treatment of above-mentioned conditions. Increasing incidence of cancers and other disorders for which leuprolide acetate is used as a therapeutic drug can drive the global leuprolide acetate market growth during the forecast period.

Market Dynamics:

Rising prevalence of prostate cancer, breast cancer, endometriosis and uterine fibroids across the globe can drive the global leuprolide acetate market growth. According to World Cancer Research Fund, prostate cancer is the second most commonly diagnosed cancer in men globally. Favorable drug approval scenario and increasing healthcare expenditure in developing nations can drive the market growth. However, high costs associated with leuprolide acetate drugs and preference of alternative treatment options in some countries can hamper the market growth. Ongoing research & development activities for development of innovative drug delivery systems of leuprolide acetate can provide potential opportunities for market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global leuprolide acetate market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global leuprolide acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Takeda Pharmaceuticals, Livzon Pharmaceutical, Beijing Biote, Sanofi, Sun Pharmaceutical, AbbVie, and Pfizer.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global leuprolide acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leuprolide acetate market

Detailed Segmentation-

• By Application
  • Prostate Cancer
  • Endometriosis
  • Uterine Fibroids
  • Central Precocious Puberty
  • Infertility
  • Hormone Therapy
  • Others
• By Product Form
  • Pre-filled Syringes
  • Vials
  • Lyophilized Powder
• By Route of Administration
  • Intramuscular
  • Subcutaneous
  • Intranasal
  • Implantation
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Key Players Insights
  • Sun Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Ferring Pharmaceuticals
  • GSK (GlaxoSmithKline)
  • Bayer AG
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Aurobindo Pharma
  • Amgen Inc.
  • EMD Serono, Inc.
  • Novartis AG
  • Sandoz International GmbH
  • Apotex Inc.
  • Fresenius Kabi AG
  • Bausch Health Companies Inc.
  • Hetero Labs Limited
  • Zydus Cadila
  • Cipla Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Leuprolide Acetate Market, By Application
  • Global Leuprolide Acetate Market, By Product Form
  • Global Leuprolide Acetate Market, By Route of Administration
  • Global Leuprolide Acetate Market, By Distribution Channel
  • Global Leuprolide Acetate Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Leuprolide Acetate Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Prostate Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Endometriosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Uterine Fibroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Central Precocious Puberty
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Infertility
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hormone Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Leuprolide Acetate Market, By Product Form, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pre-filled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Lyophilized Powder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Leuprolide Acetate Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Subcutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Intranasal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Implantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Leuprolide Acetate Market, By Distribution Channel, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Leuprolide Acetate Market, By Region, 2019 - 2031, USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific

9. Middle East

• Introduction
• Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
• Introduction
• Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
• Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ferring Pharmaceuticals
• GSK (GlaxoSmithKline)
• Bayer AG
• Pfizer Inc.
• Hikma Pharmaceuticals PLC
• Aurobindo Pharma
• Amgen Inc.
• EMD Serono, Inc.
• Novartis AG
• Sandoz International GmbH
• Apotex Inc.
• Fresenius Kabi AG
• Bausch Health Companies Inc.
• Hetero Labs Limited
• ZydusCadila
• Cipla Limited

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us